MBX Biosciences (MBX) Cash from Operations (2023 - 2026)
MBX Biosciences (MBX) reported Cash from Operations of 20208000.0 for Q1 2026, up 10.89% on a YoY basis from 18223199.62 in Q1 2025, and down 10.42% sequentially from 18301000.0 in Q4 2025.
MBX Biosciences (MBX) Cash from Operations (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Cash from Operations data on file, last reported at 20208000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 10.89% year-over-year to 20208000.0; the trailing twelve-month figure through Mar 2026 stood at 77479000.0 (down 16.25% YoY), and the FY2025 full-year result was 79949000.0, down 46.21% from the prior year.
- Cash from Operations declined to 20208000.0 in Q1 2026, from 18301000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 10710000.0 in Q1 2024 to a low of 22678000.0 in Q1 2025.
- A 4-year average of 16598400.0 and a median of 16735500.0 in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 111.75% in 2025 and grew 10.89% in 2026, its largest moves.
- Tracing MBX's Cash from Operations over 4 years: stood at 11146000.0 in 2023, then sank by 43.88% to 16037000.0 in 2024, then fell by 14.12% to 18301000.0 in 2025, then slipped by 10.42% to 20208000.0 in 2026.
- Business Quant data shows MBX's Cash from Operations at 20208000.0 in Q1 2026, 18301000.0 in Q4 2025, and 21536000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | -20.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.21 Mn |
| Mar 31, 2026 | -20.21 Mn |
| Dec 31, 2025 | -18.30 Mn |
| Dec 31, 2025 | -18.30 Mn |
| Sep 30, 2025 | -21.54 Mn |
| Sep 30, 2025 | -21.54 Mn |
| Jun 30, 2025 | -17.43 Mn |
| Jun 30, 2025 | -17.43 Mn |
| Mar 31, 2025 | -22.68 Mn |
| Mar 31, 2025 | -22.68 Mn |
| Dec 31, 2024 | -16.04 Mn |
| Dec 31, 2024 | -16.04 Mn |
| Sep 30, 2024 | -14.66 Mn |
| Sep 30, 2024 | -14.66 Mn |
| Jun 30, 2024 | -13.27 Mn |
| Jun 30, 2024 | -13.27 Mn |
| Mar 31, 2024 | -10.71 Mn |
| Mar 31, 2024 | -10.71 Mn |
| Dec 31, 2023 | -11.15 Mn |
| Dec 31, 2023 | -11.15 Mn |